| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers K > Headlines for K-V Pharmaceutical Co. > News item |
K-V Pharmaceutical reports $2.3 million of operating income for June
By Caroline Salls
Pittsburgh, July 16 - K-V Pharmaceutical Co. posted operating income of $2.3 million for June on net revenue of $8.58 million, according to its monthly operating report filed July 15 with the U.S. Bankruptcy Court for the Southern District of New York.
Those figures compare to $1.6 million of operating income reported for May on net revenue of $8.77 million.
The net loss from continuing operations was $6.78 million in June, growing from $3.15 million in May.
The company also reported cash and cash equivalents of $39.05 million as of June 30, up from $38.62 million at the end of May.
K-V Pharmaceutical, a St. Louis specialty pharmaceutical company, filed for bankruptcy on Aug. 4, 2012. Its Chapter 11 case number is 12-13346.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.